Introduction {#S0001}
============

Cystic fibrosis (CF) is a complex multi-system rare disease, but lung disease accounts for nearly 85% of the mortality. Influenza is strongly associated with pulmonary exacerbations, higher hospitalization, disease progression and increased propensity for bacterial infections.^[1](#CIT0001),[2](#CIT0002)^

Annual influenza vaccination is considered the best protection against influenza infection and is recommended for these patients by the European Cystic Fibrosis Society Vaccination Group.^[3](#CIT0003)^

In the Community of Madrid (CM) influenza vaccination is recommended and administered free of charge to the population aged 60 and over, in the patients with chronic medical conditions, pregnant women, some professional groups and people who live with or care for persons at high risk of serious influenza complications. Flu vaccines are administered in primary care health centers, accredited private medical centers, hospitals, nursing homes, prisons, etc. As in previous years, flu vaccination campaign messages diffusion is tailored to general population and is disseminated via posters, fact sheets and adverts in media. The 2015 campaign also included SMS (short message service) reminders with the recommendation for vaccination against influenza to high risk population.

Text-messaging interventions (SMS) have proved to be cost-effective to improve health and care delivery, reminding appointment attendance, adherence to treatment and better self-management.^[4](#CIT0004)^ A recent systematic review described that patient's reminders probably improved receipt of influenza vaccinations based on moderated certainty evidence.^[5](#CIT0005)^

In 2015 the Madrid Regional Health Authority implemented the information system for Rare Diseases (SIERMA), as part of the Spanish Rare Diseases Registry,^[6](#CIT0006)^ improving epidemiological information on CF.

The objectives of this study were: 1) to analyze the influenza vaccine coverage (IVC) in CF patients in the CM during the 2015 influenza vaccination campaign; and 2) to evaluate the factors associated with the IVC, including the effect of text-message/SMS vaccination reminders.

Results {#S0002}
=======

A total of 445 CF patients were analyzed, 93.3% Spanish-born, 51.5% women and 34.4% under 15 years old ([Table 1](#T0001)). The median age was 22.0 (interquartile range 14.0). The most common comorbidity was diabetes mellitus (19.8%).10.1080/21645515.2018.1520585-T0001Table 1.Characteristics of patients with cystic fibrosis registered in SIERMA. Community of Madrid, 2015 (N = 445, 229 women and 216 men).CharacteristicsSEXMenWomenTotalN (%)N (%)N (%)**Age group**   6 months-14 years80 (37.0)73 (31.9)153 (34.4)≥15 years136 (63.0)156 (68.1)292 (66.6)**Origin**   Immigrant14 (6.5)16 (7.0)30 (6.7)Autochthonous202 (93.5)213 (93.0)415 (93.3)**Comorbidities**   Diabetes39 (18.1)49 (21.4)88 (19.8)Asthma29 (13.4)22 (9.6)51 (11.5)COPD10 (4.6)16 (7.0)26 (5.8)Cardiopathy2 (0.9)4 (1.7)6 (1.3)**Number of comorbidities**   0144 (66.7)148 (64.6)292 (65.6)≥172 (33.3)81 (35.4)153 (34.4)**Previous influenza vaccination (≥3 campaigns)**105 (48.6)105 (45.9)210 (47.2)**Pandemic influenza vaccination (2009)**124 (57.4)130 (56.8)254 (57.1)**Influenza vaccination in 2014**145 (67.1)148 (64.6)293 (65.8)[^1]

In 2015, IVC reached 67.9% (70.7% women and 64.8% men, p-value = 0.18) ([Table 2](#T0002)). No statistically significant differences were observed with respect to IVC in 2014 (67.0%; p-value = 0.85). IVC was higher in children (81.0% vs. 61.0% adults, p-value \< 0.01) and in autochthonous population (60.9% vs. 40.0% in foreign-born, p-value \< 0.01). Cardiopathy was the comorbidity with higher vaccination coverage (100.0%; six cases). In patients vaccinated in three or more previous campaigns the coverage was 91.0%.10.1080/21645515.2018.1520585-T0002Table 2.Influenza vaccination coverage in patients with cystic fibrosis and factors associated to vaccination in the bi and multivariable analysis. Community of Madrid 2015.CharacteristicsCoverage\
N (%)cOR (CI95%)aOR (CI95%)**Total**302 (67.9)  **Sex**   Men140 (64.8)11Women162 (70.7)1.31 (0.88--1.97)\*\*1.93 (1.13--3.28)**Age\***    ≥15 years178 (61.0)11 6 months--14 years124 (81.0)2.74 (1.71--4.37)2.72 (1.48--4.99)**Origin\***    Immigrant12 (40.0)1  Autochthonous290 (60.9)3.48 (1.63--7.44) **Comorbidities**    Diabetes     No247 (69.2)1   Yes55 (62.5)0.70 (0.46--1.21)  Asthma     No265 (67.3)1   Yes37 (72.5)1.28 (0.67--2.46)  COPD     No287 (68.5)1   Yes15 (57.7)0.62 (0.28--1.40)  Cardiopathy     No296 (67.4)    Yes6 (100)- **Number of comorbidities**    0203 (69.5)1  ≥199 (64.7)0.80 (0.53--1.22) **Number of previous influenza vaccination\***   \<3111 (47.2)1  ≥3191 (91.0)11.20 (6.57--19.20) **Pandemic influenza vaccination**\*   No101 (52.9)11 Yes201 (79.1)3.38 (2.23--5.12)3.07 (1.79--5.29)**Influenza vaccination in 2014**\*   No44 (28.9)11 Yes258 (88.1)18.10 (11.00--29.76)14.36 (8.48--24.32)[^2]

Patients who were vaccinated in the previous year had the highest probability of being vaccinated in 2015 (aOR 14.36; IC95%: 8.48--24.32) ([Table 2](#T0002)). Women and children under 15 years of age had almost two or three times more probability of being vaccinated than men and adults, respectively.

Two hundred and twenty-one cases were vaccinated within the first four weeks after the beginning of the flu campaign ([Figure 1](#F0001)) and 9% of them (CI95% 5.9--13.6%) have not been vaccinated the previous year. Two hundred and five SMS were sent and 77 cases were vaccinated afterwards. Of them, 29.8% (CI95% 20.8--40.8%) had not been vaccinated the previous year. The probability of being vaccinated after receiving the SMS was more than twice than for those who did not receive the SMS, although no statistical significance was reached (cOR: 2.26 CI95% 0.72 to 7.04).10.1080/21645515.2018.1520585-F0001Figure 1.Influenza vaccination in patients with cystic fibrosis, Community of Madrid 2015: before and after an SMS reminder and percentage of patients unvaccinated in the previous year.

Discussion {#S0003}
==========

To the best of our knowledge, this is the first report on IVC for CF patients from a population-based registry in Spain. The IVC in 2015 was higher in children. The main factor associated with flu vaccination was having been vaccinated in the previous year. The SMS might encourage vaccination of people who had never received the influenza vaccine before.

The IVC for CF patients in this study was similar to that reported by other authors in other countries. Two studies from the USA described an IVC of 76.4% in 1997, 88.9% in 2010 and 91.0% in 2011.^[7](#CIT0007),[8](#CIT0008)^ Within Europe, in the United Kingdom, one study reported that 65% of CF patients under 18 years old were vaccinated against influenza in 2003.^[9](#CIT0009)^ A multicenter study in France estimated an IVC of 79.9% in 2005,^[10](#CIT0010)^ and two more recent studies in that country considering children, described similar IVC in 2007 and 2010 (around 67.0%).^[11](#CIT0011),[12](#CIT0012)^ Finally, one study from Italy reported for children an IVC of 91.2% in 2009.^[13](#CIT0013)^ Comparisons should be made with caution, most of the studies were based in specialized centers and higher coverages have been attributed to the management of this complex disease in these centers.^[10](#CIT0010)^

Several studies have found higher flu vaccination rates in children than in adults with CF^[7](#CIT0007),[10](#CIT0010),[14](#CIT0014)^ reaching more than 80%,^[10](#CIT0010),[13](#CIT0013)--[15](#CIT0015)^ and exceeding the coverage seen in children with other risk conditions.^[15](#CIT0015)^ Nevertheless, one study described that IVC in children decreased with increasing age.^[13](#CIT0013)^ It has been observed that children with CF are advised to receive an influenza vaccination more often compared to patients with other chronic diseases.^[13](#CIT0013)^ However, an Australian retrospective audit of immunization registers of children with CF aged 6 months to 7 years found that only 27% were given influenza vaccine in 2007, although 92% were up to date with routine immunisations.^[16](#CIT0016)^ In our study, the higher coverages in CF children than in adults could be explained at least partially by the fact that parents are responsible for their children's vaccination. Zindalini et al.^[17](#CIT0017)^ suggest that parental supervision plays a major role in adherence to medical management of CF.

The association between influenza vaccination and having received the previous seasonal or pandemic flu vaccine has already been described^[18](#CIT0018)^ and highlights the importance of the first uptake to engage with influenza immunization as an usual behaviour.

Although the impact of the SMS reminder on IVC was underpowered to detect statistically significant differences, a very interesting result was the immunization after SMS delivery of unvaccinated people in the previous year (despite the non-feasibility to establish a cause-effect relationship between the SMS reception and the immunization with this type of study). Further studies should ask the patients or their parents in the case of children about the influence of the SMS reminder in the vaccination decision. Studies in the United Kingdom,^[19](#CIT0019)^ Australia^[20](#CIT0020)^ and the USA^[21](#CIT0021)^ have shown that the rate of influenza vaccination may be increased by using mobile phone-based text messages. The use of clinical records avoids potential recall and reporting biases but they have the limitation of a possible lack of registry completeness and quality. The reasons for non-vaccination or for vaccination could not be analysed in this study because this information was not available.

As a strength of this study, it is important to mention that it is a population-based one, and that is even more valuable in studies of rare diseases, due to the scarcity of cases and the lack of knowledge about them.

In conclusion, the IVC of patients with CF is high, but it still has room for improvement. The main factor associated with vaccination was being vaccinated in the previous campaign. To improve the IVC it is critical a health professional recommendation and to enhance patients education. SMS reminders sent to patients might improve influenza vaccine uptake

Materials and methods {#S0004}
=====================

This was a population-based cross-sectional study in the CM, Spain, with 6,436,996 inhabitants in 2015. The information source was SIERMA. All the cases were further ascertained through reviews of electronic medical records. Vaccination data was provided by the regional public health information system, which is maintained from clinical records.

The target study population was all people with CF older than 6 months of age at the beginning of the flu vaccination campaign (October 2015).

The variables studied were sex, age (at 30 September 2015), country of birth, the presence of other comorbidities and information on previous flu vaccinations campaigns.

An SMS reminder of the recommendation for vaccination against influenza was sent to all people with CF or their parents, who had not been vaccinated within the first four weeks after the beginning of the campaign.

A descriptive analysis of the study population was performed. The IVC was calculated according to the study variables. Categorical variables were compared using the Chi-square test. Binary logistic regression was used to identify factors associated with being vaccinated or not. The selection threshold for entry into multivariate analysis was p-value 0.20 or less. Results were expressed as crude (cOR) and adjusted odds ratios (aOR) with 95% confidence intervals (CI). Analyses were undertaken using IBM SPSS Statistics 21.0.

The study was conducted ensuring the confidentiality of the information in accordance with the legislation of SIERMA and the Spanish legislation on data protection. The prior consent of patients and approval by an ethics committee were not required, given the characteristics of the study and that legislation.
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[^1]: COPD, Chronic Obstructive Pulmonary Disease. SIERMA, Regional Rare Disease Registry.

[^2]: COPD, chronic obstructive pulmonary disease. cOR: crude odds ratio. aOR: adjusted odds ratio.

    (\*) p-value \< 0.05

    (\*\*) p-value \< 0.20
